<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-ICC-15006046</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2015-03-06</date_registration>
      <primary_sponsor>Peking Union Medical College Hospital</primary_sponsor>
      <public_title>A single-center randomized controlled trial for exploration of the efficacy and safety of adipose-derived mesenchymal stem cells covering the uterine cavity surface for the treatment of intrauterine adhesions</public_title>
      <acronym />
      <scientific_title>A single-center randomized controlled trial for exploration of the efficacy and safety of adipose-derived mesenchymal stem cells covering the uterine cavity surface for the treatment of intrauterine adhesions</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2015-05-01</date_enrolment>
      <type_enrolment />
      <target_size>One:10;Two:10;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=10517</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>intrauterine adhesions</hc_freetext>
      <i_freetext>One:Hysteroscopy, artificial cycle;Two:Hysteroscopy, adipose-derived mesenchymal stem cells;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Ding Jing</firstname>
        <middlename />
        <lastname />
        <address>No.1 ShuaiFu Road, Dongcheng District, Beijing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 18813019415</telephone>
        <email>dingdingdangdang11@126.com</email>
        <affiliation>Peking Union Medical College Hospital</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Zhu Lan</firstname>
        <middlename />
        <lastname />
        <address>No.1 ShuaiFu Road, Dongcheng District, Beijing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13911714696</telephone>
        <email>zhu_julie@vip.sina.com</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Intrauterine adhesions is due to mainly operating history of the uterine cavity, such as abortion, myomectomy, uterine curettage and other damage caused by the occurrence of endometrial lining of the uterus.</inclusion_criteria>
      <agemin>25</agemin>
      <agemax>35</agemax>
      <gender>Female</gender>
      <exclusion_criteria>There are other pathological conditions may cause abnormal vaginal bleeding, such as endometrial polyps, submucosal uterine fibroids, gynecological tumors;
1. generally poor, difficult to tolerate serious medical complications of hysteroscopic surgery;
2. reproductive system, urinary system, or with active systemic infection, surgery can be postponed until after the infection cleared;
3. coagulation disorders or are receiving therapeutic anticoagulation drugs;
4. The researchers believe there may be other medical or mental illness can not be with the completion of the investigator.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>effectiveness;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>safety;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>1990-01-01</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>